Search research articles
Contact Us
Filters
Showing results (371-380 of 405) with videos related to
Page
of 41
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 17, 2020
MHC class I and II peptide homology regulates the cellular immune response
Matthew M Halpert, Vanaja Konduri, Dan Liang, et al.
Oncoimmunology
|
October 21, 2016
Chemo-immunotherapy mediates durable cure of orthotopic K<i>ras</i><sup>G12D</sup>/p53<sup>-/-</sup> pancreatic ductal adenocarcinoma
Vanaja Konduri, Dali Li, Matthew M Halpert, et al.
International Journal of Cancer
|
October 16, 2007
Endogenous optical biomarkers of normal and human papillomavirus immortalized epithelial cells
Claudia Mujat, Cherry Greiner, Amy Baldwin, et al.
Gynecologic Oncology
|
February 1, 1988
Adriamycin and cisplatin in the treatment of stage III and IV epithelial ovarian carcinoma
W E Shelley, J C Carmichael, L B Brown, et al.
Gynecologic Oncology
|
July 1, 1987
A predictive index of cure versus no cure in advanced ovarian carcinoma patients--replacement of second-look laparotomy as a diagnostic test
J A Carmichael, W E Shelley, L B Brown, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 1, 1989
A humanized antibody that binds to the interleukin 2 receptor
C Queen, W P Schneider, H E Selick, et al.
Pediatric Surgery International
|
February 10, 2017
Guidelines for the management of postoperative obstructive symptoms in children with Hirschsprung disease
J C Langer, M D Rollins, M Levitt, et al.
Infection and Immunity
|
July 5, 2017
Genetic Adjuvantation of a Cell-Based Therapeutic Vaccine for Amelioration of Chagasic Cardiomyopathy
Vanaja Konduri, Matthew M Halpert, Dan Liang, et al.
Cancer Treatment Reports
|
March 1, 1987
Second-line chemotherapy of stage III-IV ovarian carcinoma: a randomized comparison of melphalan to melphalan and hexamethylmelamine in patients with persistent disease after doxorubicin and cisplatin
J L Pater, J A Carmichael, G V Krepart, et al.
Cancer Research
|
July 1, 1973
Improved therapeutic index of methotrexate with "leucovorin rescue"
M Levitt, M B Mosher, R C DeConti, et al.
Page
of 41
Search research articles
Search
Showing results (371-380 of 405) with videos related to
Sort By:
Page
of 41
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 17, 2020
MHC class I and II peptide homology regulates the cellular immune response
Matthew M Halpert, Vanaja Konduri, Dan Liang, et al.
Oncoimmunology
|
October 21, 2016
Chemo-immunotherapy mediates durable cure of orthotopic K<i>ras</i><sup>G12D</sup>/p53<sup>-/-</sup> pancreatic ductal adenocarcinoma
Vanaja Konduri, Dali Li, Matthew M Halpert, et al.
International Journal of Cancer
|
October 16, 2007
Endogenous optical biomarkers of normal and human papillomavirus immortalized epithelial cells
Claudia Mujat, Cherry Greiner, Amy Baldwin, et al.
Gynecologic Oncology
|
February 1, 1988
Adriamycin and cisplatin in the treatment of stage III and IV epithelial ovarian carcinoma
W E Shelley, J C Carmichael, L B Brown, et al.
Gynecologic Oncology
|
July 1, 1987
A predictive index of cure versus no cure in advanced ovarian carcinoma patients--replacement of second-look laparotomy as a diagnostic test
J A Carmichael, W E Shelley, L B Brown, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 1, 1989
A humanized antibody that binds to the interleukin 2 receptor
C Queen, W P Schneider, H E Selick, et al.
Pediatric Surgery International
|
February 10, 2017
Guidelines for the management of postoperative obstructive symptoms in children with Hirschsprung disease
J C Langer, M D Rollins, M Levitt, et al.
Infection and Immunity
|
July 5, 2017
Genetic Adjuvantation of a Cell-Based Therapeutic Vaccine for Amelioration of Chagasic Cardiomyopathy
Vanaja Konduri, Matthew M Halpert, Dan Liang, et al.
Cancer Treatment Reports
|
March 1, 1987
Second-line chemotherapy of stage III-IV ovarian carcinoma: a randomized comparison of melphalan to melphalan and hexamethylmelamine in patients with persistent disease after doxorubicin and cisplatin
J L Pater, J A Carmichael, G V Krepart, et al.
Cancer Research
|
July 1, 1973
Improved therapeutic index of methotrexate with "leucovorin rescue"
M Levitt, M B Mosher, R C DeConti, et al.
Page
of 41